MTOR and cancer: The PI3K/Akt signaling pathway and the mammalian target of rapamycin (mTOR) signaling pathways are two pathways crucial to many aspects of cell growth and survival in cancers (18), and a recent study has revealed that INPP4B suppressed the PI3K/Akt/mTOR signaling in cervical cancer cells (14).